Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06746571

Role of Cbc Indices in Acute Lymphoblastic Leukemia Patients

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Sohag University · Academic / Other
Sex
All
Age
5 Years – 50 Years
Healthy volunteers
Not accepted

Summary

Role of cbc indices in acute lymphoblastic leukemia patients to explore the prognostic role of them in prediction the response to induction chemotherapy

Detailed description

Role of neutrophil to lymph ratio , lymphocyte to monocyte ratio and platelet to lymphocyte in acute lymphoblastic leukemia adults and pediatric patients to explore the prognostic role of them in prediction the response to induction chemotherapy

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTcomplete blood countmeasure cbc and blood ratios to compare their values with respone of patients to treatment

Timeline

Start date
2025-01-15
Primary completion
2026-01-15
Completion
2026-01-15
First posted
2024-12-24
Last updated
2024-12-24

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06746571. Inclusion in this directory is not an endorsement.

Role of Cbc Indices in Acute Lymphoblastic Leukemia Patients (NCT06746571) · Clinical Trials Directory